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ABSTRACT
Conditional inactivation of individual genes in mice
using site-specific recombinases is an extremely
powerful method for determining the complex roles
of mammalian genes in developmental and tissue-
specific contexts, a major goal of post-genomic
research. However, the process of generating mice
with recombinase recognition sequences placed at
specific locations within a gene, while maintaining a
functional allele, is time consuming, expensive and
technically challenging. We describe a system that
combines gene trap and site-specific DNA inversion
to generate mouse embryonic stem (ES) cell clones
for the rapid production of conditional knockout
mice, and the use of this system in an initial gene trap
screen. Gene trapping should allow the selection of
thousands of ES cell clones with defined insertions
that can be used to generate conditional knockout
mice, thereby providing extensive parallelism that
eliminates the time-consuming steps of targeting
vector construction and homologous recombination
for each gene.
INTRODUCTION
Recombinase-mediated, conditional gene inactivation (1–3)
has emerged as a powerful genetic method for the determina-
tion of the complex function of genes in mammals in vivo.
While permanent germline gene inactivation in embryonic
stem (ES) cells using insertional mutagenesis techniques
has been developed in commercial and academic settings
to provide large-scale genome coverage (4–6), similar
approaches for conditional mutagenesis are not currently
available. We have developed a system for conditional gene
inactivation in the mouse based on recombinase-mediated,
unidirectional DNA inversion that can provide substantial
coverageof the mouse genome.In this system, a gene trap vec-
tor is randomly integrated into mouse ES cells in a manner that
allows identiﬁcation of the integration site, reactivation of
the allele by removal of the trap cassette and subsequent
conditional inactivation of the trapped gene. The basis of the
conditional gene inactivation is a genetic element that is tran-
scriptionally silent when inserted within an intron; when
inverted by site-speciﬁc recombination, the element disrupts
endogenous mRNA production from the locus of integration.
Here, we describe the design of the high throughput, condi-
tional gene inactivation system, provide in vitro and in vivo
evidence in support of inversion-based gene inactivation and
report the results of aninitial EScell screen resulting in EScell
clones that are available to make mice suitable for conditional
gene inactivation by crosses with speciﬁc Cre-expressing
transgenic mice.
MATERIALS AND METHODS
Plasmid constructs
OppositelyorientedmutantloxP(mLoxP)(7)andequivalently
oriented Flp recombinase recognition sites (FRT) (8) were
synthesized and subcloned into pGEM-T (pGEM-loxP2 and
pGEM-FRT2). The GT cassette (pGEM-GT) was assembled
by subcloning PGK-TK, the PGK promoter upstream of the
puromycin phosphotransferase gene, and conserved splice
donor sequences into pGEM-FRT2 (EvoRV). The GI cassette
(pGEM-GI) was made by inserting the human bcl-2 gene
intron 2/exon 3 splice acceptor (9), the internal ribosome
entry site of the encephalomyocarditis virus (10), an enhanced
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doi:10.1093/nar/gni016green ﬂuorescent protein (eGFP) reporter gene and the bovine
growth hormone polyadenylation signal sequence (11) (pA)
intopGEM-mloxP2(EcoRV).To construct theelectroporation
vector, the GT cassette ﬂanked by FRT sites was released from
pGEM-GT using NotI and XhoI and subcloned into the same
sites in the pGEM-GI vector in the opposite orientation of the
GT cassette (referred to pGEM-rGT-GI), then released by
XhoI and SalI digestion and circularly ligated with a human
immunoglobulin G coding region used to protect critical
sequences from nuclease digestion (12).
ThepCAGGS-GI/rGI-nlsDsRED constructs fortransfecting
mammalian cells were generated by replacing the Cre/polyA
coding sequence in the pCAGGS-nlsCre vector (13) with a
DsRED (Clontech)/pA fragment and inserting the GI cassette
into the intron between the promoter and nlsDsRED in both
orientations.
Genome walking and bioinformatics
Selected ES cell clones were screened by Southern blotting for
single or multiple insertions by probing EcoRI digested
DNA with an eGFP fragment. The genome insertion site of
clones with a single insertion was then determined by genome
walking to obtain sequence on either side of the inserted cas-
sette, using a modiﬁcation of a method to amplify sequence
between a single gene-speciﬁc primer and an unphospho-
rylated linker (14). Brieﬂy, a double-stranded linker with an
Tsp509I overhang was annealed from complementary single-
strand oligonucleotides as shown below.
ES cell DNA was digested by Tsp509I, ligated to the
unphosphorylated linker with T4 DNA ligase and column
puriﬁed to remove excess linker. Oligonucleotide primers
complimentary to the linker cassette and to either the 50 or
30 end of the gene trap (GT) cassette were used to amplify
DNA between the cassette and the linker. The PCR products
were diluted and ampliﬁed for the second time using a pair of
nested primers complimentary to the trap cassette and linker
(LCS1 and LCS2 above indicate the ﬁrst and second round
linker primers). The PCR products from the second round
were sequenced directly after column puriﬁcation. The tagged
sequences were mapped to the mouse genome (NCBI Mouse
build 32) by NCBI BLAST, using the Ensembl mouse 20.32b
for gene annotation and a cutoff E-value for the BLAST anal-
ysis as 1 · 10
 10 (15,16). The top 10 blast targets and the DNA
transcripts in the targeted region were manually evaluated
using a visualization tool that we developed. Only insertions
of correct orientation within an annotated gene or ab initio
gene prediction are reported (17).
Cell transfection
HEK293 cells were transfected with 0.8 mg of pCAGGS-
revIC-nlsDsRED or pCAGGS-IC-nlsDsRED plasmid with
and without 0.8 mg pCAGGSnls-cre plasmid DNA using 2 ml
Lipofectamine 2000 (Invitrogen) for each well. Stable inte-
grations were obtained by antibiotic selection and individual
clones that had ﬂipped to green were manually picked twice
into 96 well plates for further expansion. Two of the eight
colonies selected appeared 100% positive for eGFP and were
transfected with Cre recombinase as described above and
ﬂuorescence recorded at 24 and 48 h after transfection. As
a positive control, a stable HEK293 cell line carrying
pCAGGS-IC-nlsDsRED was also transfected to insure Cre
recombinase activity.
In vitro recombination assay
GI cassette plasmid DNA (2 mg, pGEM-GI) was incubated
with Cre recombinase protein (80 U) in recombination buffer
at 37 C. Aliquots were removed at time points indicated and
placed in 5 mlo f5 · cold stop buffer (0.2% SDS, 40 mM
EDTA and 2 mg/ml proteinase K). DNA was extracted and
digested by BamH1 and Xho1 at 37 C for 2 h. The DNA
digestion pattern was examined by electrophoresis in a
0.8% agarose gel.
Transgenic mice
The pCAGGS-rGI transgene was prepared by replacing nlsCre
in pCAGGS-nlsCre with the opposite orientation of the GI
cassette. DNA was puriﬁed using a QIAEX II kit and injected
into C57BL/6J · DBA/2J F2 zygotes by standard pronuclear
microinjection techniques. Three founder lines were estab-
lished on C57BL/6 backgrounds and crossed with Cre mice
driven by the smMHC promoter (18) or an unpublished line
developed by us that produces ubiquitous early embryonic Cre
expression.
RESULTS
Description of the conditional gene inactivation
system: the double switch system
The design of the gene trap/conditional gene inactivation vec-
tor is shown schematically in Figure 1A. The vector relies on
two separate cassettes ﬂanked by different site-speciﬁc DNA
recombination recognition sequences, allowing for discrete
control of each cassette. The GT cassette, consisting of a
ubiquitous promoter (PGK), positive selection marker and
splice donor sequence, is used to select for random integra-
tions in mouse ES cells that have capturedan endogenous gene
polyadenylation signal (4,19–22). The GT cassette, ﬂanked
by FRT, is removed from ES cell clones by transfection
with Flp recombinase after conﬁrmation of the integration
site, restoring the allele to functionality (Figure 1B, ﬁrst
switch). To facilitate selection for ES cell clones in which
the GT cassette has been removed, the cassette includes a
negative selection element.
The gene inactivation (GI) cassette provides for conditional
inactivation of genes in which intronic integration has
occurred (Figure 1B). The basis of gene inactivation is a
recombinase-mediated, unidirectional DNA inversion from
transcriptionally silent to transcriptionally active mode. The
GI cassette is in the opposite orientation of the GT cassette to
prevent recognition of the strong splice acceptor (SA) [human
bcl-2 gene intron 2/exon 3 splice acceptor (9)] and poly-
adenylation (pA) signal sequences within the trapped locus;
an IRES and eGFP reporter sequence serve to report the ori-
entation of the GI cassette. These elements are ﬂanked by
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irreversible deletion of a ﬂanked sequence (23,24). The
mLoxP sequences are oriented in opposite directions to pro-
mote unidirectional inversion of the intervening sequence
upon exposure to Cre recombinase (25). Thus, mice produced
from ES cells containing the GI cassette in its anti-promoter
orientation should have a functional allele, but when crossed
with transgenic mice expressing Cre recombinase in a tissue-
speciﬁc or temporally controlled manner, the transcriptionally
silentGIcassetteisirreversiblyinvertedandafusiontranscript
of the truncated endogenous gene and the GI cassette formed
by splicing, resulting in the expression of the reporter gene and
premature termination of the endogenous gene mRNA
(Figure 1B, second switch).
Transcriptional control by the recombinase-mediated
unidirectional DNA inversion
The effectiveness of a DNA inversion strategy to inactivate
mouse genes in a conditional manner relies on several factors.
The inserted GI cassette must not alter the expression of the
trapped or targeted gene in its initial (inverted with respect
to the endogenous promoter or anti-promoter) orientation,
thereby insuring that the allele is functional in the absence
of recombinase expression; once inverted by the recombinase
Figure 1. Vectorsandconditionalgeneinactivationsystem.(A)Schematicrepresentationofthegenetrapvector.GI,geneinactivation;GT,genetrapcassettes;SA,
splice acceptor; pA, polyadenylation signal; Neg, negative selection cassette; mLoxP, mutant LoxP sequence; LE, RE, left and right LoxP elements; PS, protection
sequence to protect vector from exonuclease digestion; FRT, Flp recombinase recognition site; PGK-Puro-SD, phosphoglycerate kinase promoter directing
expression of the puromycin phosphotransferase gene followed by a splice donor sequence; and PGK-TK-pA, the same promoter driving the thymidine kinase
coding sequence for negative selection. (B) Schematic representation of double switch system. The GI cassette is transcriptionally inactive until inverted in vivo.
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the expression of the endogenous gene so that full gene
inactivation is achieved; and inversion of the DNA element
in vivo must be efﬁcient and unidirectional for the switch to
be effective.
To determine the extent to which the GI cassette satisﬁes
these conditions, we constructed reporter vectors incorporat-
ing the cassette in a manner that allowed determination of its
transcriptional activity. The GI cassette, containing the ﬂank-
ing mLoxP sequences and the eGFP reporter, was placed in the
ﬁrst intron of the b-actin gene, downstream of the pCAGGS
promoter (13), in either the anti-promoter or promoter orien-
tation. The DsRED coding sequence with nuclear localization
signal (nlsDsRED) was inserted downstream of the GI cassette
in the second exon of the b-actin construct (Figure 2A).
Optical separation of the ﬂuorescence signals, as well as
the nuclear localization of DsRED compared with the
cytosolic expression of eGFP, allowed us to independently
assess the orientation and transcriptional activity (silent or
truncating) of the GI cassette, as well as the efﬁciency of
recombinase-mediated inversion following transfection with
Cre recombinase. HEK293 cells were transiently transfected
with these constructs and examined at 24 and 72 h following
transfection. As shown in Figure 2B (left panel), the expres-
sion of the GI cassette in its anti-promoter orientation resulted
in the robust expression of the downstream reporter gene,
DsRED. In two such experiments, the percentage of cells
expressing DsRED was 24.5 and 30.8% 24 hafter transfection,
values roughly equivalent to the transfection efﬁciency of the
experiment, indicating no detectable disruption of the down-
stream allele. However, when the GI cassette was inserted in
the promoter orientation (Figure 2B, right panel), virtually all
Figure 2. Orientation-dependenttranscriptionalactivityofthegeneinactivationcassette.(A)Schematicrepresentationofreportervectors.ThenlsDsREDsequence
was inserted into the second exon of the b-actin gene (arrow denotes remaining partial second exon) and the GI cassette (containing IRES-eGFP) inserted in anti-
promoter (rev) and promoter orientations. (B) Vectors were transfected into HEK293cells. In the anti-promoter orientation, no eGFP activitywas observed and the
constructhadnoeffectondsREDexpression(topleft),whereasinthepromoterorientation,theGIcassetteablatedexpressionDsRED(topright)andtheexpression
of eGFP was equivalent to control plasmid transfections. Subsequent transfection of these cultures with Cre recombinase resulted in conversion to the opposite
transcriptional state at 24 h. Note transient transfection and protein lifetime prevents evaluation of extent of conversion.
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eliminated, whereas 32 and 48% were eGFP positive in two
separate experiments. In these experiments, the percentage of
eGFP positive cells was within the range of transfection efﬁ-
ciencies observed in our experiments (varied between 10 and
73% in all experiments), and the brightness of individual cells
was equivalent to that observed with transient transfection of
eGFP expression plasmids, indicating that the GI cassette
pseudo exon was incorporated into RNA by the transcriptional
machinery in a highly efﬁcient manner and produced a robust
transcriptional block. Experiments in which a Cre recombi-
nase expression plasmid was co-transfected with the inverted
GI constructs resulted in the expected manipulation of the
GI cassette; 90% of transfected cells (expressing either
ﬂuorophore) were eGFP positive. Similarly, 79% of cells
co-transfected with Cre and the GI cassette in the promoter
orientation (green) ﬂipped to red (Figure 2). Because the tran-
sient transfection of the constructs and the stability of the
translated proteins precluded a clear assessment of the efﬁ-
ciency of DNA inversion, we constructed stable cell lines
with the same constructs. In four such experiments, 27.6%
of cells were ﬂipped from one orientation to the other (range
of 15–44%), a ﬁgure close to the transfection efﬁciency for
these experiments.
Figure 3. Unidirectional DNA inversion by mLoxP sequences in vitro.( A) Plasmid components with Xho1 and BamH1 sites. The insert and plasmid backbone are
2.6 and3.0 kb, respectively. Digestionofthe vector in theconstructedorientationresultsin 2.0 and3.6 kb(3.0 plasmid+ 0.6insert)products.Inversionof theinsert
reducesthesizeoftheinsertfragmentto0.6kb,resultingina5kbproduct.(B)PlasmidattopwasexposedtoCrerecombinaseproteinforthetimesshown,digested
withBamH1andXho1andseparatedonagarosegel(above).The2.0and3.6kbbandsareeliminatedwithincreasingtimeofexposuretotheenzymeandthepredicted
5 kb band is seen (0.6 kb band not shown). The graph (below) shows densitometric quantification of the original 3.6 kb band.
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(23), which have previously been shown to promote
irreversible gene deletion (24), in catalyzing the required uni-
directional DNA inversion. LoxP recognition sequences
placed in opposite orientations lead to Cre recombinase cat-
alyzed inversion of the intervening sequence, such that at
equilibrium 50% of the intervening sequence is in each ori-
entation (23,26). As shown in Figure 3, restriction digest anal-
ysis of plasmid DNA containing the GI cassette ﬂanked by
oppositely oriented mLoxP sites indicated that Cre recombi-
nase protein resulted in a rapid and unidirectional inversion of
the cassette in vitro, resulting in a predictable alteration in
DNA fragment sizes. Greater than 90% of the DNA was
inverted within 1 h of exposure to 80 U Cre recombinase at
37 C, indicating efﬁcient recognition of the mutant sequence
by Cre recombinase, and a markedly reduced binding afﬁnity
for the recombined sequence.
The unidirectional nature of this inversion was further con-
ﬁrmed in cells containing stable insertions of the GI cassette.
In these experiments, the reporter construct described above,
containing an antibiotic resistance cassette, was transfected in
its anti-promoter (red) orientation and stable integrants were
selected with G418. Surviving cells displayed no eGFP ﬂuo-
rescence and were virtually all positive for DsRED. These
cells were transfected with Cre recombinase and eGFP posi-
tive clones manually picked twice to obtain homogenous
eGFP-expressing cultures, in which the GI cassette had
been ﬂipped into the same orientation as the upstream pro-
moter. As shown in Figure 4, subsequent transfections of these
cells with Cre recombinase failed to produce any DsRED-
positive cells, indicating that once inverted, the GI cassette
could no longer ﬂip to the anti-promoter orientation, whereas
transfection of control cells stably expressing the cassette in
the promoter (green) orientation with Cre recombinase
resulted in the marked expression of DsRED. These results
indicate that once inverted, the GI cassette is insensitive to the
recombinase.
Transfection of cell lines may result in a far greater expres-
sion of Cre recombinase than can be achieved in vivo in the
mouse. To conﬁrm the effectiveness of DNA inversion in a
more practical context, we created lines of transgenic mice, in
which the transgene consisted of the GI cassette, ﬂanked by
mLoxP sites (Figure 5A), was inserted in the pCAGGS plas-
mid (13) in the opposite orientation of the CMV promoter/
b-actin enhancer. Hemizygous GI
+ mice were crossed with
mice expressing Cre recombinase under control of the smooth
muscle-speciﬁc myosin heavy chain promoter (18), or with
mice that direct Cre expression to all tissues of the early
embryo (K.-Y. Deng, H.-B. Xin and M.I. Kotlikoff, manuscript
in preparation), and tissues analyzed for ﬂuorescence and con-
struct orientation to determine the extent to which the cassette
is inverted in vivo. As shown in Figure 5B, PCR analysis of the
tissues of offspring from these crosses using primers speciﬁc
for the promoter orientation of the GI cassette indicated that
only double transgenic (Cre
+/GI
+) mice contained the ﬂipped
cassette, and that this orientation of the cassette was speciﬁc to
tissues in which Cre recombinase expression was directed. In
litters from two separate founders, three-week-old double
transgenic (GI
+/smCre
+) mice displayed robust eGFP ﬂuores-
cence conﬁned to vascular and nonvascular smooth muscle
tissues (Figure 5C), consistent with the cellular expression of
Cre recombinase. Mice carrying the GI cassette but not the Cre
transgene never displayed eGFP ﬂuorescence. Moreover,
analysis of offspring from crosses producing early embryonic
expression of Cre recombinase resulted in a generalized
inversion of the GI cassette, as indicated by robust ﬂuores-
cence of all cells in 8 and 18.5 day mice (Figure 5D).
Gene trapping and determination of insertion site
Unlike insertional mutagenesis in which 30 RACE can be used
to identify a disrupted exon sequence, conditional gene inac-
tivation by DNA inversion and transcriptional block requires
intronic insertion, and unambiguous determination of the site
of vector integration is therefore necessitated. To test the
described vectors and establish the feasibility of identiﬁcation
strategies, a gene trap screen was conducted in R1 ES cells by
electroporating cells in the presence of gene trap vector DNA
(Figure 1A). Cells were selected with puromycin for produc-
tive integrations and resistant clones transferred to triplicate
96 well plates, one of which was used to make DNA for
Figure 4. Unidirectional DNA inversion in vivo. Left, cells were selected for
stableexpressionoftheGIcassetteinitstranscriptionallysilent(anti-promoter,
red)orientation,transfectedwithCrerecombinaseexpressionplasmidtoinvert
the cassette, and green clones selected. Top and middle are eGFP and DsRED
images of same fields. Following an additional transfection with Cre recombi-
nase, no inversion of the previously flipped cassette occurred (bottom, DsRED
image). Right, control cells stably transfected with the GI cassette in its tran-
scriptionally active (promoter, green) orientation demonstrated robust gene
inversion when transiently transfected with Cre recombinase. Bottom images
taken 48 h post-Cre transfection.
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blotting with an eGFP fragmentafter digestionwith EcoR1. Of
239 resistant clones,asingleband wasidentiﬁed in136 clones,
with multiple bands in 64 clones and no evidence of insertion
in the remaining clones.
Several sequencing strategies were pursued to obtain
genomic sequence ﬂanking the integrated vector. The most
successful method was a modiﬁcation of a genome walking
procedure (14), which allowed unambiguous determination of
the exact site of vector integration in a high percentage of
cases. Ampliﬁcation of ﬂanking DNA by genome walking
resulted in useable sequence from one end or both ends of
the cassette in 81 (60%) of the single integrants. As shown in
Table 1, our bioinformatics strategy resulted in the iden-
tiﬁcation of the locus of insertion in 39 clones, or 48% of
the clones in which ﬂanking sequence was obtained. This is
a conservative estimate, as only known or ab initio predicted
genes were considered in the analysis, whereas in many cases,
Figure 5. Recombinase-mediated DNA inversion in transgenic mice. (A) Transgene containing the GI cassette (with eGFP reporter) driven by the pCAGGS. (B)
GenotypingofF1offspringofGI
+andCrerecombinasetransgenicmiceexpressedinsmoothmuscle(lanes1–3)orwholeembryo(lane4).Onlymiceinlanes3and4
expressed both the GI and Cre recombinase transgenes. Using primers specific for the inverted form of the cassette, a PCR product was detected in DNA prepared
from smoothmuscle tissue (lane 3) or whole embryo (lane 4) only in mice expressing both transgenes.(C) Tissue from double transgenic micewith smoothmuscle
restricted Cre expression. Left, light (above) and fluorescent (below) images of urinary bladders from Cre
 ,GI
+ (left) and Cre
+,GI
+ mice (middle and right); 0.8·.
Right, superimposed light and fluorescent image of artery from Cre
 ,GI
+ mouse shows fluorescence restricted to smooth muscle; 10·.( D) Left, light (above) and
fluorescent (below) images of tails from 18.5 day mice. Tails at left and right: Cre
+,GI
+; tails in middle: Cre
 ,GI
+. Fluorescence is muted by pigment in tail at left.
Right, fluorescent image of 8 day Cre
+,GI
+ mouse upper body tissues.
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the local sequence by Genscan suggested the presence of a
potential gene locus, within which the vector was appropri-
ately oriented to capture the polyadenylation sequence. In
addition, although ﬂanking sequences allowed determination
of the site of integration in over 90% of the clones examined,
in many cases the trapped polyadenylation sequence could not
be unambiguously determined and was therefore not listed.
These failures could be attributed to incomplete annotation or
inadequate sequence (a substantial number of insertions in
which the gene locus could not be identiﬁed occurred in
areas of the genome that contain substantial sequence
gaps), but could also result from the trapping of pseudo
polyadenylation sequences that are not associated with an
endogenous gene. Of the unambiguous integrants shown in
Table 1, 56% were intronic, whereas 28% occurred in the
50-untranslated region (50-UTR), an average of 114 bp from
the start of exon 1. Thus, in this screen  10% of all resistant
clones could be identiﬁed as intronic insertions in known
genes.
DISCUSSION
Our experiments demonstrate the practical basis of the
unidirectional DNA inversion for the production of condi-
tional knockout mice. We have shown that (i) the inserted
DNA vector is transcriptionally silent before activation;
(ii) following unidirectional inversion the vector powerfully
disrupts transcription; (iii) unidirectional inversion of the cas-
sette can be efﬁciently achieved in cells and in transgenic
mice; (iv) gene trapping results in numerous single intronic
insertions within endogenous genes; (v) the GT cassette can be
readily removed leaving the transcriptionally silent inverted
element; and (vi) the site of insertion is easily determined.
Taken together, these experiments indicate that unidirectional
Table 1. List of trapped genes and insertion sites
Gene trap clones
Clone Location Intron/exon Gene Annotation
AB4 11:46999933 Intron 2 (4) GENSCAN00000030349 Unknown
AB6 3:20959528 50 UTR (1.2 kb) Genscan prediction Unknown
AB7 19:4600746 50 UTR (147 bp) ENSMUSG00000006456 Rbm14 Unknown function, RNA-binding region
RNP-1 (RNA recognition motif)
AB10 19:9205621 50 UTR (73) ENSMUSG00000044504 Zbtb3, zinc finger and BTB domain containing 3
AB23 Y:3064117 Intron 3 (9) ENSMUSG00000053211 Zfy1, zinc finger protein 1, Y linked
AB24 1:24787681 Intron 1 (16) ENSMUSG00000026139 LMBR membrane protein (lipocalin like motif)
AB34 5:129049765 30 UTR (1.2 kb) ENSMUSESTG00000024736 Unknown
AB35 8:97091210 50 UTR (48 bp) ENSMUSESTG00000002583 Unknown
AB41 11:14526302 Intron 2 (3) GENSCAN00000063363 Nuclear envelope pore membrane protein POM 121
AB45 3:33612037 50 UTR (5) ENSMUSG00000027671 53 kDa BRG1-associated factor A (actin-related
protein BAF53A)
AB52 15:83418824 50 UTR (108 bp) ENSMUSG00000022478 Phf5a (PHD finger protein 5a)
AB57 13:97799446 Exon 1(1) GENSCAN00000141083 Unknown
AB60 7:37794879 50 UTR (119 bp) ENSMUSG00000025389 Lens fiber major intrinsic protein (mip26)
AB61 9:46147000 50 UTR (307) ENSMUSG00000032115 Hyou1 Cab140) hypoxia up-regulated 1
AB72 18:84776833 Intron 1(5) GENSCAN00000002917 Unknown
AB82 15:77123042 Intron 4(7) ENSMUSG00000053168 Ly6c lymphocytes antigen LY-6C precursor
AB112 15:91187795 50 UTR (72 bp) ENSMUSG00000022618 Chk1, choline/ethanolamine kinase
AB122 14:110179384 Intron 1(2) ENSMUSESTG00000021020 Unknown
AB162 9:63143799 Intron 3(5) GENSCAN00000046398 Unknown
AB166 1:108891482 Exon 2(2) ENSMUSG00000048549 Bcl2. apoptosis regulator
AB167 6:104002195 Intron 2(21) ENSMUSG00000030075 Cntn3, contactin 3; plasmacytoma-associated neuronal
glycoprotein
AB172 7:NT_081205 Exon 1(9) GENSCAN00000100015 Unknown
AB179 15:77109835 Intron 3(5) ENSMUSG00000053168 Ly6c, similar to lymphocyte antigen 6 complex, locus I
AB191 X:81394369 Intron 2(3) GENSCAN00000021466 Unknown
AB203 8:95320457 50 UTR (191 bp) ENSMUSG00000033009 Prolyl 4-hydroxylase, alpha subunit
AB208 3:30902840 Intron 1(15) ENSMUSG00000027684 Evi1, ecotropic viral integration site 1 (embryonic lethal)
AA3 7:66130092 50 UTR (74) ENSMUSESTT00000000727 Unknown
AA4 9:125575183 Intron 1(5) ENSMUSG00000035498 Unknown
B6 15:9404595 Intron 4(6) ENSMUSG00000055463 Unknown
B2 19:35685964 Intron 1(3) GENSCAN00000029475 Unknown
AC2 X:125314423 Intron 1(3) ENSMUSESTT00000005143 Morf4l2, transcription factor-like protein MORF-related
gene X protein. Splice variant
AE1 4:117345976 Intron 11(21) GENSCAN00000056387 Cdc20, cell division cycle protein 20 homolog. Splice variant
AD2 14:16382207 Intron 2(3) GENSCAN00000011182 Unknown
AD8 1:134403527 Intron 1(2) GENSCAN00000079343 Unknown
AE2 11:118712586 Intron 3(12) ENSMUSG00000039976 Unknown, RabGAP/TBC domain
AF2 11:70076743 Exon 1 (5) ENSMUSG00000018919 Tm4sf5, transmembrane 4 superfamily, member 5,
unknown function
AG2 1:63421977 Intron 1(3) ENSMUSESTG00000010455 Unknown
AG9 2:32724693 Exon 1(2) ENSMUSG00000039164 Unknown
AH2 17:8732662 Intron 1(2) GENSCAN00000120409 Unknown
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expression in vivo. The combination of unidirectional gene
inversion with gene trap methods provides a high-
throughput method for the generation of knockout mice.
We used a gene trap vector designed for electroporation to
conduct a small-scale screen for ES cells with single, intronic
insertions. The overall throughput for unambiguous insertions
of this nature was 10%, which when scaled should yield many
hundreds of useful clones. Throughput would likely be mark-
edly enhanced by incorporation of the cassettes within a
retroviral vector, providing for more efﬁcient transfer of the
vector and increasing the percentage of single insertions (27).
Additionally, replacement of the GT cassette (Figure 1A)
with an FRT-ﬂanked selection cassette oriented inverse to
the inactivation cassette, and ﬂanking both cassettes with
homologous sequences, enables the system’s use as a targeted
replacement vector. In this application, the vector would be
targeted to an intron, which simpliﬁes vector construction as
minor PCR errors and frame shifts are not a concern; alter-
natively, the vector could be targeted to an intronic locus in a
mouse bacterial artiﬁcial chromosome to produce highly
efﬁcient targeting vectors (28–31). These application would
extend the utility of inversion-based gene inactivation, as gene
trap approaches are limited by several factors including poor
accessibility of some genes, a relatively high percentage of
trapped sequences that are not expressed as mRNA and
recombinations at the site of insertion (32,33).
A key requirement in the implementation of a gene
trapping/conditional knockout strategy is the determination
of the location of insertion of the vector, insuring that inser-
tion is intronic and allowing a determination of the likely
functional result of transcriptional termination at the insertion
site. In cases of gene overlap, knowledge of the insertion site
is particularly important. The genome walking method
described here allows rapid and efﬁcient determination of
ﬂanking sequence, and the attendant employment of bio-
informatics strategies to rapidly determine the location of
the insertion and the identity of the gene locus from sequence
databases. Determination of the insertion site was achieved
in 60% of the single insertion clones, and repeated
analysis of the other clones would probably improve this
percentage. A signiﬁcant limitation in the use of the sequence
information was ambiguity as to the trapped gene locus; as
mammalian gene annotation continues, we anticipate atten-
dant improvements in the determination of functionally rele-
vant insertions.
One limitation of the described transcriptional arrest strat-
egy should be noted: the assumption of conservation of func-
tion of a trapped allele following removal of the GT cassette
assumes minimal transcriptional effects associated with the
intronic insertion of the GI cassette. As cis transcriptional
effectsassociated with intronic insertionsare well documented
andcanresultininefﬁcientoraberrant RNAsplicing(34,35),a
careful evaluation of the transcriptional function ofthe trapped
allele seems prudent. We have not evaluated this effect as its
importance will depend on the nature of the insertion (which
intron and where within the intron), as well as the extent of
alternative splicing of the speciﬁc gene. We also note that the
described ES cell collection can also be used to create mice
with a constitutively inactivated allele by inverting the GI
cassette in vitro and retaining the GT cassette.
While still emerging, conditional gene expression strategies
in the mouse have already had major impacts on cancer bio-
logy and immunobiology. It is likely that temporal and tissue-
speciﬁc control of the expression of virtually all clinically
relevant genes will be achieved in the mouse over the next
two decades. The above described system should provide im-
portant advantages in the achievement of this goal, and should
also be useful for the functional annotation of genes of other
eukaryotic species.
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